Knockout Mice Model Market Growth and Sales Forecast 2017-2025

A knockout mouse is a laboratory mouse (a biological model) in which a target gene has been disrupted or inactivated. The loss of gene activity frequently results in changes in the mouse's phenotypic characteristics (behavior, appearance, and other observable biochemical characteristics). This, in turn, allows in vivo studies of gene function, disease research, and drug development. Knockout mice are a powerful tool for analyzing gene function during development and in disease process.

View Report-
https://www.transparencymarketresearch.com/knockout-mice-model-market.html

Emergence of CRISPR as a powerful tool in the field of biomedical research, rising burden of obesity, increasing prevalence of cancer, cardiovascular diseases, diabetes, autism, schizophrenia, and rare diseases are some of the pivotal factors that are anticipated to propel the demand of knockout mice models in the near future.

Incessant grants/funds supporting cancer research studies, agreements & collaborations strengthening cancer research, increasing biomedical research activities in prominent markets such as the U.S., Australia, rising pharmaceutical & biotechnology R&D activities in Korea, increasing translational and biomedical research in Singapore, international alliances for R&D activities, growing public and private investments in life sciences sector, upsurge in animal research in Malaysia, growing pharmaceutical, biotechnology & research industries in Brazil, Saudi Arabia and the UAE are other driving factors that are expected to provide impetus to the market.

Brochure Download-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39248

Increasing focus of associations such as International Mouse Phenotyping Consortium (IMPC) & International Knockout Mouse Consortium (IKMC) on the development of knockout mice is likely to unlock new areas of biology and lead to novel drug target discovery. .

In terms of types, the knockout mice models market has been divided into conditional knockout, constitutive knockout, inducible knockout, and tissue-specific knockout. Conditional knockout mice models are made by engineering recombinase specific targets. This enables the deletion of a gene in a tissue- and time-specific manner. Constitutive knockout mice models are created to carry an inoperative gene. It permanently inactivates a target gene in every cell of the organism. Inducible knockout mice models are conditional biological models, in which target gene of interest can be inactivated at a given point of time. It inactivates gene expression in a time-controlled manner. Tissue-specific knockout mice models are conditional biological models, in which target gene can be inactivated in a specific tissue or tissues such as the brain, intestine, muscles, skin, and all the other tissues.

Request For Custom Research-
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39248

In terms of type of indications, the knockout mice model market has been further classified into obesity, cancer, cardiovascular diseases, diabetes, neurological disorders, and others. Knockout mice models for cancer, cardiovascular diseases, diabetes & neurological disorders segments are well-established and hence their availability for these indications is not a concern. However, the supply of knockout mice models for neurological disorders and rare diseases is low; therefore, their availability for these indications is a concern. The knockout mice models for obesity, cancer, cardiovascular diseases, diabetes are priced relatively lower than the knockout models for neurological disorders and rare diseases due to the demand-supply gap. Based on geography, the knockout mice model market is segment into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Key players operating in the global knockout mice model market are Charles River Laboratories, Inc., The Jackson Laboratory, ENVIGO (Harlan Laboratories, Inc.), Taconic Biosciences, Inc., genOway, Cyagen Biosciences, Inc., Horizon Discovery Group PLC (Sage Labs, Inc.), Deltagen (TRANS GENIC INC.), and Ozgene.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us-
90 State Street,
Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.